Benefit and risk evaluation of quinapril hydrochloride
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2023.2203481
Abstract: ABSTRACT Introduction Angiotensin-converting enzyme (ACE) inhibitors are a mainstay of antihypertensive therapy. Quinapril hydrochloride, a less commonly used, and less-studied ACE inhibitor has been approved for its primary use in hypertension. Studies also indicate its… read more here.
Keywords: benefit risk; quinapril hydrochloride; quinapril; ace ... See more keywords